Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 937,639 |
|
|||||
| News | (5) | ||||||
| Day High | 22.29 | Low High |
|||||
| Day Low | 21.26 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kura Oncology Inc | KURA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.30 | -1.36% | 21.76 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 21.72 | 21.26 | 22.29 | 21.76 | 22.06 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,764 | 937,639 | US$ 21.91 | US$ 20,540,422 | - | 7.41 - 24.17 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:27:43 | formt | 21,036 | US$ 21.76 | USD |
Kura Oncology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.66B | 76.14M | - | 0 | -152.63M | -2.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kura Oncology News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KURA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 20.92 | 22.29 | 20.37 | 21.35 | 602,336 | 0.84 | 4.02% |
| 1 Month | 20.95 | 23.10 | 20.02 | 21.55 | 610,089 | 0.81 | 3.87% |
| 3 Months | 21.94 | 23.10 | 16.79 | 20.52 | 778,840 | -0.18 | -0.82% |
| 6 Months | 11.16 | 24.17 | 10.33 | 18.54 | 1,197,152 | 10.60 | 94.98% |
| 1 Year | 13.57 | 24.17 | 7.41 | 15.09 | 989,746 | 8.19 | 60.35% |
| 3 Years | 21.22 | 24.17 | 7.41 | 15.04 | 834,416 | 0.54 | 2.54% |
| 5 Years | 16.57 | 42.82 | 6.34 | 17.71 | 716,594 | 5.19 | 31.32% |
Kura Oncology Description
| Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. |
